ArticleVeterinary and animal science2026
Development of an RT-LAMP-CRISPR/Cas12a-based nucleic acid detection platform for rapid diagnosis of porcine reproductive and respiratory syndrome virus type 2.
Article in Veterinary and animal science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Porcine reproductive and respiratory syndrome virus (PRRSV) significantly affects swine production, leading to reproductive failure and respiratory disorders. Current detection methods are limited by slow turnaround times, insufficient sensitivity and specificity, the need for skilled personnel, and costly equipment, which hinder their application in rapid on-site diagnosis and early disease prevention and control. In this study, a novel detection platform was developed by integrating the target specificity of RT-LAMP primers with the dual recognition capability of CRISPR/Cas12a. Optimal crRNA primers targeting conserved sequences in the PRRSV-2 structural protein M gene were designed and screened. Reaction conditions were subsequently optimized, and a cloning vector containing the target gene was constructed. Sensitivity evaluation using PCR, LAMP-CRISPR/Cas12a, and qPCR revealed detection limits of 9.17 × 10
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.